NCT03546816 Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis Status COMPLETED Phase PHASE3
NCT03540160 Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch) Status TERMINATED Phase PHASE3
NCT03483870 Effect of Granisetron on Morphine Induced Pruritus in Cesarean Section Status COMPLETED Phase PHASE2
NCT03464526 A Study of the Efficacy and Safety of Orvepitant in Subjects With Pruritus Associated With Atopic Dermatitis Status WITHDRAWN Phase PHASE2
NCT03448081 Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene Status COMPLETED Phase PHASE2
NCT03343639 Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT03322137 Safety, Efficacy, and Tolerability of SNA-120 in Subjects With Pruritus Associated With Psoriasis Vulgaris Status COMPLETED Phase PHASE2
NCT03317301 Evaluate the Efficacy and Safety of HL151 Versus Talion Tab. in Pruritus Cutaneus Status COMPLETED Phase PHASE3
NCT03262038 Does IV Ondansetron Prevent Pruritus After Intrathecal Morphine in Pediatric Patients? Status TERMINATED Phase PHASE4
NCT03209427 Serum Serotonin and Pruritus After Intrathecal Morphine in Cesarean Section Status COMPLETED Phase PHASE4
NCT03132142 Desensitization of Nociceptive Afferents by Application of Topical Capsaicin, Trans-cinnamaldehyde and L-menthol Status UNKNOWN Phase NA
NCT03096444 Antipruritic Effect of Topical Ketamine, Amitriptyline, and Lidocaine Status TERMINATED Phase PHASE2
NCT03035942 Quality of Recovery After Dexamethasone, Ondansetron or Placebo Intrathecal Morphine Administration Status COMPLETED Phase PHASE4
NCT02975271 Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury Status TERMINATED Phase PHASE2